Skip to Content
Merck
All Photos(1)

Documents

T1978000

Tricaprylin

European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Glyceryl trioctanoate, 1,2,3-Tricapryloylglycerol, 1,2,3-Trioctanoylglycerol, Glycerol tricaprylate, Glycerol trioctanoate, Glyceryl tricaprylate, Tricaprylin, Trioctanoin

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
[CH3(CH2)6COOCH2]2CHOCO(CH2)6CH3
CAS Number:
538-23-8
Molecular Weight:
470.68
Beilstein:
1717202
MDL number:
MFCD00036236
UNSPSC Code:
41116107
PubChem Substance ID:
329826698
NACRES:
NA.24

grade

pharmaceutical primary standard

API family

tricaprylin

manufacturer/tradename

EDQM

bp

233 °C/1 mmHg (lit.)

density

0.956 g/mL at 20 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

SMILES string

CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC

InChI

1S/C27H50O6/c1-4-7-10-13-16-19-25(28)31-22-24(33-27(30)21-18-15-12-9-6-3)23-32-26(29)20-17-14-11-8-5-2/h24H,4-23H2,1-3H3

InChI key

VLPFTAMPNXLGLX-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Tricaprylin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Storage Class Code

10 - Combustible liquids

WGK

nwg

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ken-Ichi Ogawara et al.
Journal of pharmaceutical sciences, 106(4), 1143-1148 (2017-01-09)
To develop a safer and more potent paclitaxel (PTX) formulation, we prepared various oil-in-water emulsions by using egg phosphatidylcholine, Tween 80, and a mixture of triglycerides with different fatty acid chain lengths as the cosurfactant, surfactant, and oil phase component
Masahiro Ikejiri et al.
Organic & biomolecular chemistry, 15(33), 6948-6958 (2017-08-10)
Diarylmethylenated and cholestene (or -tane)-hybrid analogues of the GFP chromophore, namely, Ch-DAINs were successfully synthesised by a condensation reaction between methyl imidates and N-(diarylmethylene)glycinates. Among the Ch-DAINs synthesised, a diphenyl-type analogue showed viscosity-dependent and cholesterol-responsive fluorescent properties. It showed a
Myeongsu Jo et al.
Foods (Basel, Switzerland), 10(4) (2021-05-01)
We prepared emulsion-filled gels stabilized using octenyl succinic anhydride-modified and pregelatinized maize starch (OSA-PGS). The effect of the oil volume fraction (Φ, 0.05-0.20) and OSA-PGS concentration (3-10% w/v) on the rheological and microstructural properties of the emulsion-filled gels was evaluated.
Anam Sajjad Khan et al.
International journal of pharmaceutics, 593, 120109-120109 (2020-12-01)
The purpose of this study was to enhance the anti-leishmanial efficacy of miltefosine (MTF) and reduce its toxic effects by loading it into nanostructured lipid carriers (NLCs). Micro-emulsion technique was used to prepare MTF-loaded NLCs. The optimized NLCs were characterized
Qi Zhang et al.
Oncotarget, 8(42), 72447-72456 (2017-10-27)
Gefitinib showed response in phase II clinical trials and with better clinical response in lung cancer with activating mutations in the tyrosine kinase domain of the EGFR. Questions of toxicity and potential dosing regimens impede the use in a prevention
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service